101 related articles for article (PubMed ID: 29768802)
1. Surgical systems biology and personalized longitudinal phenotyping in critical care.
Muirhead LJ; Kinross J; FitzMaurice TS; Takats Z; Darzi A; Nicholson JK
Per Med; 2012 Aug; 9(6):593-608. PubMed ID: 29768802
[TBL] [Abstract][Full Text] [Related]
2. Implementation of molecular phenotyping approaches in the personalized surgical patient journey.
Mirnezami R; Kinross JM; Vorkas PA; Goldin R; Holmes E; Nicholson J; Darzi A
Ann Surg; 2012 May; 255(5):881-9. PubMed ID: 22156927
[TBL] [Abstract][Full Text] [Related]
3. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.
Yurkovich JT; Tian Q; Price ND; Hood L
Nat Rev Clin Oncol; 2020 Mar; 17(3):183-194. PubMed ID: 31619755
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?
van der Greef J; Hankemeier T; McBurney RN
Pharmacogenomics; 2006 Oct; 7(7):1087-94. PubMed ID: 17054418
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling in colorectal cancer: opportunities for personalized medicine.
Zheng X; Xie G; Jia W
Per Med; 2013 Sep; 10(7):741-755. PubMed ID: 29768755
[TBL] [Abstract][Full Text] [Related]
6. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
Zhang A; Sun H; Wang P; Han Y; Wang X
Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
[TBL] [Abstract][Full Text] [Related]
7. Intestinal ischemia/reperfusion injury: defining the role of the gut microbiome.
Kinross J; Warren O; Basson S; Holmes E; Silk D; Darzi A; Nicholson JK
Biomark Med; 2009 Apr; 3(2):175-92. PubMed ID: 20477509
[TBL] [Abstract][Full Text] [Related]
8. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
Dumas ME; Kinross J; Nicholson JK
Gastroenterology; 2014 Jan; 146(1):46-62. PubMed ID: 24211299
[TBL] [Abstract][Full Text] [Related]
9. The promise of metabolic phenotyping in gastroenterology and hepatology.
Holmes E; Wijeyesekera A; Taylor-Robinson SD; Nicholson JK
Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):458-71. PubMed ID: 26194948
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine: from genotypes, molecular phenotypes and the quantified self, towards improved medicine.
Dudley JT; Listgarten J; Stegle O; Brenner SE; Parts L
Pac Symp Biocomput; 2015; ():342-6. PubMed ID: 25592594
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of plasma lipidomics in cardiovascular drug discovery.
Puri R; Duong M; Uno K; Kataoka Y; Nicholls SJ
Expert Opin Drug Discov; 2012 Jan; 7(1):63-72. PubMed ID: 22468894
[TBL] [Abstract][Full Text] [Related]
12. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Leyens L; Horgan D; Lal JA; Steinhausen K; Satyamoorthy K; Brand A
Per Med; 2014 Sep; 11(7):641-649. PubMed ID: 29764055
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Microbore UPLC-MS Metabolic Phenotyping of Urine for Large-Scale Epidemiology Studies.
Gray N; Lewis MR; Plumb RS; Wilson ID; Nicholson JK
J Proteome Res; 2015 Jun; 14(6):2714-21. PubMed ID: 25917015
[TBL] [Abstract][Full Text] [Related]
14. Glaucomics: a call for systems diagnostics for 21(st) century ophthalmology and personalized visual health.
Güngör K; Hotez PJ; Özdemir V; Aynacıoğlu Ş
OMICS; 2014 May; 18(5):275-9. PubMed ID: 24730382
[TBL] [Abstract][Full Text] [Related]
15. Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine Tools.
Björnson E; Borén J; Mardinoglu A
Front Physiol; 2016; 7():2. PubMed ID: 26858650
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.
Palmieri O; Mazza T; Castellana S; Panza A; Latiano T; Corritore G; Andriulli A; Latiano A
OMICS; 2016 Dec; 20(12):692-698. PubMed ID: 27930092
[TBL] [Abstract][Full Text] [Related]
17. 'Deep phenotyping': characterizing populations in the era of genomics and systems biology.
Tracy RP
Curr Opin Lipidol; 2008 Apr; 19(2):151-7. PubMed ID: 18388695
[TBL] [Abstract][Full Text] [Related]
18. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
